Intraday Performance and Price Movement
On 5 January 2026, Epigral Ltd’s share price touched a new 52-week low at Rs 1,157.35, representing a decline of 7.26% from the previous close. The stock’s day change registered a significant drop of 7.43%, considerably underperforming the Specialty Chemicals sector by 7.64% and the Sensex benchmark by 6.98 percentage points. This intraday low was accompanied by elevated volatility, with the weighted average price indicating a 5.39% intraday price fluctuation, underscoring the stock’s unsettled trading environment.
Recent Trend and Moving Averages
Epigral Ltd’s share price has been on a downward trajectory for the past two consecutive sessions, cumulatively falling by 8.21%. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests sustained selling pressure and a lack of short- to medium-term support levels, which may be contributing to the ongoing price weakness.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Comparative Market Context
While Epigral Ltd has been under pressure, the broader market has shown relative resilience. The Sensex index opened 121.96 points lower and closed down by 251.69 points at 85,388.36, a decline of 0.44%. Despite this, the Sensex remains close to its 52-week high of 86,159.02, just 0.9% away, and continues to trade above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling an overall bullish trend for the benchmark index. This divergence highlights the stock-specific nature of Epigral’s weakness.
Performance Over Various Time Frames
Epigral Ltd’s recent performance contrasts sharply with the broader market’s gains. Over the past week, the stock declined by 7.73%, while the Sensex gained 0.80%. The one-month return for Epigral stands at -21.35%, compared to the Sensex’s marginal decline of 0.39%. Over three months, the stock has fallen 34.18%, whereas the Sensex has appreciated by 5.13%. The one-year performance shows a 36.33% loss for Epigral against a 7.76% gain for the Sensex. Year-to-date, Epigral is down 5.25%, while the Sensex has inched up 0.18%. Longer-term comparisons reveal that over three years, Epigral’s return is -2.66%, significantly lagging the Sensex’s 41.46% gain. Over five and ten years, Epigral’s returns have remained flat, while the Sensex has surged by 76.26% and 233.75%, respectively.
Mojo Score and Market Capitalisation Assessment
Epigral Ltd currently holds a Mojo Score of 31.0, categorised under a Sell grade, which was downgraded from a Strong Sell on 26 December 2025. The company’s market capitalisation grade stands at 3, indicating a relatively modest market cap within its sector. These metrics reflect the stock’s ongoing challenges in regaining positive momentum and investor confidence.
Holding Epigral Ltd from Specialty Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Volatility and Investor Sentiment
The heightened intraday volatility of 5.39% reflects increased uncertainty and active trading in Epigral Ltd’s shares. The stock’s failure to hold above key moving averages and the establishment of a new 52-week low suggest that immediate selling pressure remains dominant. This environment indicates cautious sentiment among market participants, with the stock’s performance diverging notably from the broader market’s relative stability.
Sectoral and Industry Considerations
Within the Specialty Chemicals sector, Epigral Ltd’s underperformance today is particularly pronounced. The sector itself has not experienced comparable declines, which points to company-specific factors influencing the stock’s price action. The stock’s current trajectory and technical indicators highlight the challenges it faces in reversing the recent downtrend.
Summary of Key Metrics
To summarise, Epigral Ltd’s share price today reached an intraday low of Rs 1,157.35, down 7.26% intraday and 7.43% on the day. The stock has declined over the last two sessions by 8.21%, with significant volatility and trading below all major moving averages. Its Mojo Score of 31.0 and Sell grade reflect the prevailing negative momentum. Meanwhile, the Sensex’s modest decline of 0.44% and proximity to its 52-week high underscore the stock’s relative weakness within the market.
Investors monitoring Epigral Ltd will note the continued pressure on the stock price and the absence of technical support at current levels, which may influence trading strategies in the near term.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Today
